Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
07/2003
07/31/2003US20030143207 Remodeling of tissues and organ
07/31/2003US20030143185 Polymer conjugates of protein kinase C inhibitors
07/31/2003US20030143157 Method of treating tumors
07/31/2003CA2514088A1 Use of cholinesterase antagonists to treat insulin resistance
07/31/2003CA2511223A1 Thrombin derived peptides for promoting cardiac tissue repair
07/31/2003CA2510751A1 Multimers of receptor-binding ligands
07/31/2003CA2476773A1 Monoclonal antibodies against extracellular loops of c5ar
07/31/2003CA2474292A1 Sustained release pharmaceutical composition
07/31/2003CA2474269A1 Nutraceuticals for the treatment, protection and restoration of connective tissues
07/31/2003CA2473924A1 Systems and methods for photodynamic therapy
07/31/2003CA2473829A1 Use of tgf-.beta. antagonists to treat or to prevent chronic transplant rejection
07/31/2003CA2473796A1 Substituted quinazolin-4-ylamine analogues
07/31/2003CA2473786A1 Method of prophylaxis against large myocardial infarctions
07/31/2003CA2473781A1 Glycoisoforms of adiponectin and uses thereof
07/31/2003CA2473740A1 Methods of treating conditions associated with an edg receptor
07/31/2003CA2473707A1 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
07/31/2003CA2473545A1 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters
07/31/2003CA2473510A1 Pyrimidine derivatives as rho-kinase inhibitors
07/31/2003CA2473490A1 Peptide-carrying bodies for immune response
07/31/2003CA2473395A1 Phospholipid bodies and use thereof in medical treatment
07/31/2003CA2473386A1 Method
07/31/2003CA2473047A1 Phosphinic pseudo-peptide derivatives for selective inhibition of the active c-terminal site of angiotensin converting enzyme (i) (ace)
07/31/2003CA2472729A1 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression
07/31/2003CA2472682A1 Treating stress response with chemokine receptor ccr5 modulators
07/31/2003CA2472578A1 Anti-cancer combination and use thereof
07/31/2003CA2472367A1 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters
07/31/2003CA2472239A1 3-(imidazolyl)-2-aminopropanoic acids for use as tafi-a inhibitors for the treatment of thrombotic diseases
07/31/2003CA2472238A1 3-(imidazolyl)-2-alkoxypropanoic acids as tafia inhibitors
07/31/2003CA2471989A1 2-aminothiazole allosteric enhancers of a1 adenosine receptors
07/31/2003CA2471740A1 Pharmaceutically acceptable phosphate-glycerol carrying bodies
07/31/2003CA2471342A1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
07/30/2003EP1331224A1 Thiazole or oxazole derivatives
07/30/2003EP1331223A1 Method of treating sepsis
07/30/2003EP1331221A1 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation
07/30/2003EP1331004A2 Aminotetralin Derivative for the Therapy of Cardiovascular Diseases
07/30/2003EP1330548A2 Methods of diagnosing, preventing and treating neurological disorders and neuronal injuries
07/30/2003EP1330535A2 Kini-3 motor protein and methods for its use
07/30/2003EP1330467A2 Modified, hydroxy-substituted aromatic structures having cytoprotective activity
07/30/2003EP1330463A2 Beta-substituted beta-aminoethyl phosphonates
07/30/2003EP1330462A1 New process for the production of oxabispidines
07/30/2003EP1330461A1 New oxabispidine compound useful in the treatment of cardiac arrhythmias
07/30/2003EP1330455A1 Novel 7-azaindoles, use thereof as phosphodiesterase 4 inhibitors and method for producing the same
07/30/2003EP1330452A2 Pyrazine derivatives as modulators of tyrosine kinases
07/30/2003EP1330451A2 Substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide y modulators
07/30/2003EP1330448A2 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders
07/30/2003EP1330447A2 Peptides as met-ap2 inhibitors
07/30/2003EP1330444A2 Nitrogenous heterocyclic compounds and process for making nitrogenous heterocyclic compounds and intermediates thereof
07/30/2003EP1330442A1 Phthalazinone derivatives
07/30/2003EP1330439A1 (7-(3-carboxyphenyl)-4-chloroisoquinolin-1-yl)guanidine
07/30/2003EP1330428A1 Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and the alkanoyl l-carnitines with taurine chloride and glycine chloride
07/30/2003EP1330426A1 Selective maxi-k- potassium channel openers functional under conditions of high intracellular calcium concentration, methods and uses thereof
07/30/2003EP1330425A2 C-nitroso compounds and use thereof
07/30/2003EP1330273A1 Coated implantable medical device
07/30/2003EP1330261A2 Treatment of hibernating myocardium and diabetic cardiomyopathy with a glp-1 peptide
07/30/2003EP1330244A1 Compositions comprising modafinil compounds
07/30/2003EP1330243A2 Use of carp inhibitors for the treatment of heart diseases
07/30/2003EP1330240A2 Use of 20-hete synthesizing enzyme inhibitors as therapy for cerebral vascular diseases
07/30/2003EP1330233A1 Method of treating stroke
07/30/2003EP1233960B1 Polymorphic salt of an anti-migraine drug
07/30/2003EP1165121B1 SUPAR STIMULATING ACTIVITY OF tcuPA-MEDIATED FIBRINOLYSIS AND DIFFERENT USES THEREOF
07/30/2003EP1161234B1 Treatment of pulmonary hypertension by inhalation of benzindene prostaglandins
07/30/2003EP1112275B1 Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase
07/30/2003EP1082962B1 Utilization of 2-hydroxy-4-trifluoromethylbenzoic acid derivatives as inhibitors of the activation of the nuclear transcription factors nf-(k)b
07/30/2003EP0946541B1 Quinolines and their therapeutic use
07/30/2003EP0942780B1 Coated particles, methods of making and using
07/30/2003EP0910400B1 Therapies for chronic renal failure
07/30/2003EP0814801B1 Use of a pyruvate dehydrogenase activator for the treatment of ischaemia in limbs
07/30/2003EP0705100B1 Therapeutic substituted guanidines
07/30/2003EP0592439B1 Aminosulfonyl carbamates
07/30/2003CN1433477A Method of achieving persistent transgene expression
07/30/2003CN1433466A MASP-3, complement-fixing enzyme, and uses for it
07/30/2003CN1433427A 依匹乐酮晶型 Epinastine music one polymorph
07/30/2003CN1433424A 8 Beta-hydrocarbyl-substituted estratrienes for use as selective estrogens
07/30/2003CN1433414A Benzazole derivatives and their use as JNK modulators
07/30/2003CN1433412A Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same
07/30/2003CN1433411A Chemical compounds
07/30/2003CN1433410A CDK inhibitors having 3-hydroxychromen-4-one structure
07/30/2003CN1433408A Aminothiazole inhibitors of cyslin dependent kinases
07/30/2003CN1433407A Bis-arylsulfones
07/30/2003CN1433405A Quinazoline compounds
07/30/2003CN1433396A Pharmaceutical compounds
07/30/2003CN1433326A Method for determining viability of myocardial segment
07/30/2003CN1433325A Techniques and compositions for treating cardiovascular disease by in vivo gene delivery
07/30/2003CN1433318A Vascular endothelial growth factor-2
07/30/2003CN1433316A Biologically active agents and drugs
07/30/2003CN1433312A Barbituric acid analogs as therapeutic agents
07/30/2003CN1433311A Methods for making sustained release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
07/30/2003CN1433307A Prostaglandin compounds for treating congestive heart failure
07/30/2003CN1433303A Use of fumaric acid derivatives for treating mitochondrial diseases
07/30/2003CN1433302A Use of cortisol antagonists in the treatment for heat failure
07/30/2003CN1432652A Actinia neurotoxin gene and its application
07/30/2003CN1432651A Actinia neurotoxin gene and its application
07/30/2003CN1432650A Actinia neurotoxin gene and its application
07/30/2003CN1432649A Actinia neurotoxin gene and its application
07/30/2003CN1432401A Blood pressure lowering and heat clearing away glossy ganoderma wine
07/30/2003CN1432393A Chinese medicine prepn for treating coronary heart disease and angina pectoris and its prepn
07/30/2003CN1432387A Honeyed pill for dredging meridian passage, eliminating phlegm and expelling toxin and its prepn process
07/30/2003CN1432382A Medicine for preventing and treating coronary heart disease and its prepn process
07/30/2003CN1432363A Transdermal Ligustrazine plaster and its prepn
07/30/2003CN1432362A Oral Nimoldipine prepn and its prepn process
1 ... 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 ... 1595